page_banner

Products

Manufactur standard Pharmaceutical - DL-Norleucine Cas: 616-06-8 99% White powder – XD BIOCHEM

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We know that we only thrive if we can guarantee our combined rate competiveness and good quality advantageous at the same time for Phenylgalactoside, Fda, Featuring Flow Chemistry, Winning customers' trust is the gold key to our success! If you are interested in our products, please feel free to visit our web site or contact us.
Manufactur standard Pharmaceutical - DL-Norleucine Cas: 616-06-8 99% White powder – XD BIOCHEM Detail:

Catalog Number XD90302
Product Name DL-Norleucine

CAS

616-06-8

Molecular Formula

C6H13NO2

Molecular Weight

131.17292
Storage Details 0 – 8 °C
Harmonized Tariff Code 29224999

 

Product Specification

Assay ≥99%
Appearance White powder

 

Blends of polypropylene (PP) and polyamide 6 (PA6) with multiwalled carbon nanotubes (MWNTs) were prepared using different processing strategies in a twin-screw micro-compounder. The effect of MWNTs on the crystallization behaviour of the PP phase and the PA6 phase of the blend has been investigated through non-isothermal crystallization studies by differential scanning calorimetric analysis. Furthermore, the effect of the addition of the compatibilizer (PP-g-MA) and the modification of MWNTs (m-MWNTs) with a non-covalent organic modifier (Li-salt of 6 amino hexanoic acid, Li-AHA) has also been studied in context to the crystallization behaviour of the PP and PA6 phase in the blend. The crystallization studies have indicated a significant increase in bulk crystallization temperature of the PP phase in the blend in the presence of MWNTs. Moreover, the formation of ‘trans-lamellar crystalline’ structure consisting of PA6 ‘trans-crystalline lamellae’ on MWNTs surface was facilitated in th e case of blends prepared via ‘protocol 2′ as compared to the corresponding blends prepared via ‘protocol 1′. Wide angle X-ray diffraction analysis has showed the existence of a β-polymorph of the PP phase due to incorporation of the PA6 phase in the blend. Addition of MWNTs in the blends has facilitated further β-crystalline structure formation of the PP phase. In the presence of m-MWNTs, a higher β-fraction was observed in the PP phase as compared to the blend with pristine MWNTs. Addition of PP-g-MA has suppressed the β-phase formation in the PP phase in the blend. X-ray bulk texture analysis revealed that incorporation of PA6 as well as pristine/modified MWNTs has influenced the extent of orientation of the PP chains towards specific crystalline planes in various blend compositions of PP and PA6.


Product detail pictures:

Manufactur standard Pharmaceutical - DL-Norleucine  Cas: 616-06-8  99%  White powder – XD BIOCHEM detail pictures


Related Product Guide:

We not only will try our greatest to offer superb companies to just about every buyer, but also are ready to receive any suggestion offered by our shoppers for Manufactur standard Pharmaceutical - DL-Norleucine Cas: 616-06-8 99% White powder – XD BIOCHEM , The product will supply to all over the world, such as: Holland, Grenada, Sweden, We have been seeking the chances to meet all the friends from both at home and abroad for the win-win cooperation. We sincerely hope to have long-term cooperation with all of you on the bases of mutual benefit and common development.
  • The company has rich resources, advanced machinery, experienced workers and excellent services, hope you keep improving and perfecting your products and service, wish you better!
    5 Stars By Pearl from Brazil - 2018.02.21 12:14
    Timely delivery, strict implementation of the contract provisions of the goods, encountered special circumstances, but also actively cooperate, a trustworthy company!
    5 Stars By Hulda from luzern - 2018.11.11 19:52
    Close

    Manufactur standard Pharmaceutical - DL-Norleucine Cas: 616-06-8 99% White powder – XD BIOCHEM